Glyburide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: GK Activator (2);   Drug: GlyburideSponsor:   Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: GK Activator (2);   Drug: GlyburideSponsor:   Hoffmann-La RocheCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: GK Activator (2);   Drug: GlyburideSponsor:   Hoffmann-La RocheCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: GK Activator (2);   Drug: GlyburideSponsor:   Hoffmann-La RocheCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: GK Activator (2);   Drug: GlyburideSponsor:   Hoffmann-La RocheCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2006 Category: Research Source Type: clinical trials

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
Condition:   Diabetes Mellitus, Type 2Interventions:   Drug: Rosiglitazone;   Drug: glyburide;   Drug: metforminSponsor:   GlaxoSmithKlineCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2006 Category: Research Source Type: clinical trials